Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IgG subclasses in CAPD patients

R T Krediet1, G C Koomen, A Vlug

  • 1Renal Unit, University of Amsterdam, The Netherlands.

Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Longitudinal Membrane Function in Peritoneal Dialysis Patients According to Dialysis Fluid Biocompatibility.

Kidney international reports·2020
Same author

[Trends in emergency admissions in Amsterdam. Fifteen years of emergency psychiatry in an increasingly crowded city].

Tijdschrift voor psychiatrie·2020
Same author

Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment.

The Netherlands journal of medicine·2011
Same author

Predialytic period and baseline peritoneal membrane status: any connection?

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2010
Same author

Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease.

The Netherlands journal of medicine·2010
Same author

Encapsulating peritoneal sclerosis in patients on peritoneal dialysis.

The Netherlands journal of medicine·2008

Adults on continuous ambulatory peritoneal dialysis (CAPD) show reduced immunoglobulin G (IgG) subclasses, specifically IgG2 and IgG4. This decrease is due to lower production, not increased loss through peritoneal dialysis.

Area of Science:

  • Nephrology
  • Immunology

Background:

  • Immunoglobulin G (IgG) subclass levels can be altered in patients with chronic kidney disease undergoing dialysis.
  • Continuous ambulatory peritoneal dialysis (CAPD) involves significant protein loss in peritoneal effluent, potentially affecting immunoglobulin levels.

Purpose of the Study:

  • To compare serum IgG subclass levels in CAPD patients versus hemodialysis patients and healthy controls.
  • To determine if increased protein removal in peritoneal effluent contributes to altered IgG subclass levels in CAPD patients.

Main Methods:

  • Cross-sectional study involving 23 CAPD patients, 21 hemodialysis patients, and 21 healthy volunteers.
  • Serum IgG subclasses measured by nephelometry.
  • Peritoneal transport studies and analysis of peritoneal dialysate using ELISA.

Related Experiment Videos

Main Results:

  • CAPD patients exhibited significantly lower serum IgG2 and IgG4 levels compared to hemodialysis patients and healthy volunteers.
  • A substantial percentage of CAPD patients (43%) had low IgG2 levels, independent of peritonitis incidence.
  • Evidence suggests decreased synthesis of IgG2 and IgG4 in CAPD patients, rather than increased peritoneal loss.

Conclusions:

  • Stable adult CAPD patients demonstrate reduced serum IgG2 and IgG4 levels.
  • The primary cause of low IgG2 and IgG4 in CAPD patients is decreased synthesis, not enhanced peritoneal loss.